## Diagnosis of Culture-Negative Septic Arthritis **Key Point:** In septic arthritis with negative Gram stain and pending culture, molecular techniques (16S rRNA PCR) can rapidly identify fastidious organisms (Mycobacterium, Brucella, Neisseria, Haemophilus) that may not grow on routine culture media. ### Why Gram Stain Can Be Negative **High-Yield:** Gram stain is positive in only 50–60% of septic arthritis cases. Negative Gram stain does NOT exclude infection, especially in: - Fastidious organisms (Brucella, Mycobacterium tuberculosis, Neisseria gonorrhoeae) - Immunocompromised patients (higher risk of atypical pathogens) - Partially treated infections - Low bacterial burden ### 16S rRNA PCR: Advantages Over Culture | Feature | Culture | 16S rRNA PCR | |---------|---------|-------------| | **Sensitivity** | 50–70% | 85–95% | | **Time to result** | 48–72 hours | 24–48 hours | | **Fastidious organisms** | May miss | Detects | | **Identifies organism** | Yes (after growth) | Yes (molecular) | | **Antibiotic susceptibility** | Yes (after culture) | No (requires culture) | | **Cost** | Lower | Higher | **Clinical Pearl:** In immunocompromised patients (like this RA patient on immunosuppressants), fastidious and atypical organisms are more common. 16S rRNA PCR provides rapid organism identification while awaiting culture results, allowing earlier targeted therapy. ### Clinical Context: RA on Immunosuppression **Key Point:** Patients with rheumatoid arthritis on TNF-α inhibitors or other DMARDs have increased risk of: - Tuberculosis (including TB arthritis) - Brucellosis (if exposed) - Atypical mycobacteria - Fungal infections 16S rRNA PCR is particularly valuable in this population for early detection of these organisms. ### Diagnostic Algorithm for Septic Arthritis ```mermaid flowchart TD A[Suspected septic arthritis]:::outcome --> B[Arthrocentesis immediately]:::action B --> C[Synovial fluid analysis]:::action C --> D{Gram stain positive?}:::decision D -->|Yes| E[Organism identified]:::outcome D -->|No| F[Culture pending]:::outcome F --> G{Culture grows organism?}:::decision G -->|Yes| H[Organism + susceptibilities]:::outcome G -->|No| I[Consider 16S rRNA PCR]:::action I --> J[Fastidious organism detected?]:::decision J -->|Yes| K[Targeted therapy]:::action J -->|No| L[Consider non-infectious cause]:::outcome ``` **Warning:** Do NOT delay antibiotics while awaiting PCR results. Empiric broad-spectrum coverage should be started based on clinical suspicion and synovial fluid findings (high WBC, neutrophilia), then de-escalated once organism is identified. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.